Study at a glance
What did long-term studies examine about vitamin D, inflammation and ageing?
This page compares three long-term studies with different aims, called VITAL, DO-HEALTH and TILDA. VITAL measured blood signs of inflammation after vitamin D or placebo. DO-HEALTH tested vitamin D, omega-3 and exercise using estimates of how the body was ageing, based on DNA. TILDA observed whether starting vitamin D levels were linked with later categories of blood-sugar levels.
Did supplements change inflammation or estimates of ageing?
In VITAL, one inflammation marker was lower with vitamin D at two years, but not at four years. Other measured inflammatory substances showed no consistent benefit. In DO-HEALTH, vitamin D alone did not clearly change the four ageing estimates. Positive results involving omega-3 or combined treatments cannot be credited to vitamin D alone.
Were vitamin D levels linked with later blood-sugar problems?
In TILDA, lower starting vitamin D levels were linked with later prediabetes, meaning raised blood sugar below the diabetes range. The link with new diabetes cases was uncertain. Because researchers did not randomly assign vitamin D levels, other differences between participants could explain some of the association. One starting measurement also cannot show vitamin D levels throughout the time people were followed.
Do the studies show that vitamin D slows ageing or prevents disease?
The studies did not demonstrate a sequence in which vitamin D reduces inflammation, slows ageing of the immune system and prevents diabetes. Blood markers and DNA-based ageing estimates do not directly establish a better-working immune system or longer life. Fewer later samples, selected parts of the study groups and measurement limits add uncertainty. These studies do not establish an anti-ageing treatment or a supplement plan to prevent metabolic disease, which affects how the body processes nutrients.
Read the full article below ↓Three long-term studies examined different outcomes: inflammatory blood markers, DNA-methylation estimates of ageing and later glycaemic status. Together they do not establish that vitamin D reduces chronic inflammation, rejuvenates immunity and prevents metabolic disease. Their value lies in showing which parts of that proposed sequence have evidence and which links remain unproven. Read the companion Vitamin D, Long-Term Inflammation, Biological Ageing and Metabolic Risk: Full Evidence Review.
Inflammatory markers: VITAL
Dong and colleagues analysed inflammatory markers in a VITAL subgroup assigned vitamin D or placebo. The sample included 1,054 participants at baseline, with fewer available at later visits. Most were not below the reported vitamin D deficiency threshold.
High-sensitivity C-reactive protein was lower with vitamin D at two years, but the finding was absent at four years. IL-6, IL-10 and TNF-α measurements did not show a consistent beneficial pattern. Some IL-6 values were outside the quantifiable assay range, limiting interpretation.
This is evidence about selected measurements relevant to Vitamin D and Chronic Inflammation, not proof of sustained suppression of every inflammatory process. It does not demonstrate that a marker difference caused a clinical benefit.
Biological-age estimates: DO-HEALTH
The DO-HEALTH analysis examined 777 older Swiss participants in a factorial trial of vitamin D, omega-3 and exercise. Vitamin D alone did not clearly change the four DNA-methylation clock measures considered. Some omega-3 and combination findings were positive, but a combined intervention result cannot be attributed independently to vitamin D.
These clocks are research estimates, not direct measurements of lifespan or immune competence. The study therefore does not establish improved immune function with ageing, the broader topic discussed in Vitamin D and Immune Ageing. Its post hoc subset design and endpoint multiplicity also require caution.
Metabolic outcomes: TILDA
McCarthy and colleagues related baseline vitamin D concentrations to later glycaemic status in an observational cohort. Lower vitamin D categories were associated with incident prediabetes over four years compared with the highest reference category. The incident-diabetes association was not clear and had substantial uncertainty.
Participants were not randomly assigned their vitamin D status. Residual confounding, a single baseline measurement and selection at follow-up limit causal interpretation. The study concerns later glycaemic classification; it did not directly demonstrate altered insulin signalling, the cellular process discussed in Vitamin D and Insulin Signalling.
Why the findings cannot be joined into a causal chain
The studies did not show that low vitamin D caused inflammation that then caused immune ageing or diabetes. In particular, the TILDA association was not demonstrated to be mediated by inflammation. A temporary hs-CRP difference in a separate trial cannot supply that missing mechanism.
The studies also measured different populations and outcomes. Epigenetic clocks, circulating proteins and HbA1c-based glycaemic categories are not interchangeable measures of one biological process. Vitamin D, Ageing, and Real-World Context provides wider context for interpreting ageing-related research without treating every surrogate as a real-world functional benefit.
The VITAL markers do not identify a specific mechanism among the pathways discussed in Vitamin D and Inflammatory Signalling. Nor do they prove correction of excessive immune activation, as discussed in Vitamin D and Immune Overactivation. Likewise, these analyses did not establish oxidative stress as the mediator between vitamin D status and metabolic outcomes; Vitamin D and Oxidative Stress explains that related physiological topic. These questions remain distinct from the measurements actually made.
Conclusion
The evidence supports a time-limited inflammatory-marker finding, no clear independent vitamin D effect on the selected ageing clocks, and an observational association with prediabetes. It does not establish an anti-ageing or metabolic-prevention regimen, and the research doses are not personal treatment recommendations.
This page is an original Vitamin D3 For Life explanation and critical appraisal of the research cited below.
Primary source and publication details
Related reading
Appraising the role of circulating concentrations of micronutrients in attention deficit hyperactivity disorder: a Mendelian randomization study
Previous observational researches have discovered a connection between circulating concentrations of micronutrients and attention deficit hyperactivity disorder (ADHD).
Original paper ↗Read more →Baseline Vitamin D Levels on Quality of Life and Pain Perception Among Patients with Chronic Pain with Long-Term Prescription Opioid Use: A Prospective Study
We prospectively studied 45 patients with chronic pain with long-term prescription opioid usage who were selected for elective detoxification.
Original paper ↗Read more →Determinants of long‐term paramagnetic rim lesion evolution in people with multiple sclerosis
Baseline paramagnetic rim lesion (PRL) load predicts disease progression in people with multiple sclerosis (pwMS).
Original paper ↗Read more →Diet quality is associated with malnutrition and low calf circumference in Canadian long-term care residents
The purpose of this study was to determine diet quality of Canadian LTC residents and its association with malnutrition and low calf circumference.
Original paper ↗Read more →Integrative analysis of blood biochemistry and sperm metabolome profiles reveals metabolic determinants of cryotolerance in Bali bulls under standardized nutritional conditions
Enhancing the nation’s beef supply and guaranteeing long-term food security require increasing the effectiveness of artificial insemination (AI) in Bali cattle (Bos javanicus).
Original paper ↗Read more →Long Term Association between Serum 25-Hydroxyvitamin D and Mortality in a Cohort of 4379 Men
Based on the same study population, the primary aim of the present study was to investigate the association between s-25(OH)D and total mortality.
Original paper ↗Read more →Long-term comorbidity associated with childhood periodic fever, aphthous stomatitis, pharyngitis, and adenitis (PFAPA) syndrome: a case-control study
The aim of this study was to evaluate the long-term morbidity of patients with PFAPA compared with controls selected from the general population.
Original paper ↗Read more →Long-term growth and final adult height outcome in childhood-onset systemic lupus erythematosus
This study aimed to determine the predictors of growth impairment in such patients.
Original paper ↗Read more →Long-Term Impact of Multiple Micronutrient Supplementation on Micronutrient Status, Hemoglobin Level, and Growth in Children 24 to 59 Months of Age: A Non-Randomized Community-Based Trial from Pakistan
Children aged 24 to 48 months old were recruited and allocated to the intervention and control arm of the study.
Original paper ↗Read more →Long-Term Prognosis in Relation to Vitamin D Status in Pediatric Solid Tumor Patients
The purpose of our study was to follow up pediatric cancer patients for a long time in terms of their baseline Vitamin D level and disease outcomes.
Original paper ↗Read more →Long-term trajectories of peak expiratory flow rate in older men and women show linear decline mainly determined by baseline levels
Peak expiratory flow rate (PEFR) predicts mortality and other negative health outcomes.
Original paper ↗Read more →Long-Term Vitamin D Deficiency Results in the Inhibition of Cell Proliferation and Alteration of Multiple Gastric Epithelial Cell Lineages in Mice
We found that the membrane VD receptor is expressed widely in the stomach when compared to nuclear VD receptors.
Original paper ↗Read more →Long-term yogurt intake and colorectal cancer incidence subclassified by Bifidobacterium abundance in tumor
Evidence suggests a tumor-suppressive effect of the intake of yogurt, which typically contains Bifidobacterium.
Original paper ↗Read more →Low vitamin D levels and the long‐term functional outcome of stroke up to 5 years
The purpose of this study was to investigate the relationship between vitamin D and 5‐year outcome of patients with stroke including acute ischemic stroke (AIS) and intracranial hemorrhage (ICH) stroke.
Original paper ↗Read more →Parathyroid carcinoma: from diagnostic challenges to surgical management and long-term outcomes: A single-center retrospective analysis
Parathyroid carcinoma (PC) is a rare malignant tumor, accounting for.
Original paper ↗Read more →Potential Effects of a Modified Mediterranean Diet on Body Composition in Lipoedema
Lipoedema is a subcutaneous adipose tissue disease characterized by the increase in the amount and structure of fat mass (FM) in specific areas, causing pain and discomfort.
Original paper ↗Read more →Prognosis of Dermatitis Herpetiformis Patients with and without Villous Atrophy at Diagnosis
The objective of this study was to investigate whether the presence or absence of villous atrophy at diagnosis affects the long-term prognosis of DH.
Original paper ↗Read more →Serum 25-Hydroxyvitamin D Concentrations Are Associated with Mental Health and Psychosocial Stress in Young Adults
We aimed to test the hypothesis that serum 25-hydroxyvitamin D3 (25(OH)D) concentration is associated with mental health and life stress measures in young adults and investigate gender and racial disparities in these associations.
Original paper ↗Read more →Symptoms, nutritional outcomes and quality of life after total gastrectomy with Roux-en-Y reconstruction: results of a cross-sectional study conducted on 80 long-term survivors
The primary aim of this study was to investigate the long-term postoperative functional and nutritional results after Roux-en-Y total gastrectomy (RYTG).
Original paper ↗Read more →Vitamin D treatment attenuates 2,4,6-trinitrobenzene sulphonic acid (TNBS)-induced colitis but not oxazolone-induced colitis
Crohn’s disease (CD) and ulcerative colitis (UC) have different immunological mechanisms, while both of them are potential targets of vitamin D treatment.
Original paper ↗Read more →Effects of Vitamin D3 and Marine Omega-3 Fatty Acids Supplementation on Biomarkers of Systemic Inflammation: 4-Year Findings from the VITAL Randomized Trial
Background: The VITAL study was a nationwide, randomized, double-blind, placebo-controlled, 2 × 2 factorial trial of vitamin D3 (2000 IU/day) and marine n-3 FAs (1 g/day) supplements.
Original paper ↗Read more →Original sources
Effects of Vitamin D3 and Marine Omega-3 Fatty Acids Supplementation on Biomarkers of Systemic Inflammation: 4-Year Findings from the VITAL Randomized Trial
Background: The VITAL study was a nationwide, randomized, double-blind, placebo-controlled, 2 × 2 factorial trial of vitamin D3 (2000 IU/day) and marine n-3 FAs (1 g/day) supplements.
Publication details
Effects of Vitamin D3 and Marine Omega-3 Fatty Acids Supplementation on Biomarkers of Systemic Inflammation: 4-Year Findings from the VITAL Randomized Trial. Yanbin Dong, Haidong Zhu, Li Chen, Ying Huang, William Christen, Nancy R Cook, Trisha Copeland, Samia Mora, Julie E Buring, I-Min Lee, Karen H Costenbader, JoAnn E Manson. Nutrients; 2022; 14; 24; 5307. DOI: 10.3390/nu14245307. CC BY. This page provides an original explanatory appraisal; no source figures are reproduced.
Individual and additive effects of vitamin D, omega-3 and exercise on DNA methylation clocks of biological aging in older adults from the DO-HEALTH trial
Individual and additive effects of vitamin D, omega-3 and exercise on DNA methylation clocks of biological aging in older adults from the DO-HEALTH trial.
Publication details
Individual and additive effects of vitamin D, omega-3 and exercise on DNA methylation clocks of biological aging in older adults from the DO-HEALTH trial. Heike A. Bischoff-Ferrari, Stephanie Gängler, Maud Wieczorek, Daniel W. Belsky, Joanne Ryan, Reto W. Kressig, Hannes B. Stähelin, Robert Theiler, Bess Dawson-Hughes, René Rizzoli, Bruno Vellas, Laure Rouch, Sophie Guyonnet, Andreas Egli, E. John Orav, Walter Willett, Steve Horvath. Nature Aging; 2025; 5; 3; 376 to 385. DOI: 10.1038/s43587-024-00793-y. CC BY. This page provides an original explanatory appraisal; no source figures are reproduced.
Association between vitamin D deficiency and the risk of prevalent type 2 diabetes and incident prediabetes: A prospective cohort study using data from The Irish Longitudinal Study on Ageing (TILDA)
Association between vitamin D deficiency and the risk of prevalent type 2 diabetes and incident prediabetes: A prospective cohort study using data from The Irish Longitudinal Study on Ageing (TILDA).
Publication details
Association between vitamin D deficiency and the risk of prevalent type 2 diabetes and incident prediabetes: A prospective cohort study using data from The Irish Longitudinal Study on Ageing (TILDA). Kevin McCarthy, Eamon Laird, Aisling M O’Halloran, Cathal Walsh, Martin Healy, Annette L Fitzpatrick, James B Walsh, Belinda Hernández, Padraic Fallon, Anne M Molloy, Rose Anne Kenny. eClinicalMedicine; 2022; 53; 101654. DOI: 10.1016/j.eclinm.2022.101654. CC BY. This page provides an original explanatory appraisal; no source figures are reproduced.